Photo of Larry Bucshon
R United States House · District 8 · Indiana

Rep. Larry Bucshon

Compare
Total votes
2,168
all sessions
Attendance
97%
75 missed
Near the chamber average
With party
91%
of cast votes
Lower than 88% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 87% of chamber peers
Sponsored
556
bills & resolutions
Near the chamber average
Committees
0
assignments
556 bills and resolutions

Sponsored bills

Total
556
Primary
36
Co-sponsor
520
This page
556
matching current filters
Co-sponsor HR 5761
In committee · United States House · Co-sponsor
Pay Our Correctional Officers Fairly Act

Pay Our Correctional Officers Fairly Act This bill provides increased locality pay rates to certain Bureau of Prisons employees whose duty stations are located in the pay locality designated as Rest of U.S. The Rest of U.S. GS (general schedule) locality is the default locality area that applies to GS employees in any city that does not fall within another specified GS locality. Such an employee shall not be subject to this bill if his or her official work site is not located within 100 miles of any pay locality other than Rest of U.S .

In committee Oct 27, 2021 1 co-sponsor
Co-sponsor HR 5735
In committee · United States House · Co-sponsor
State, Local, Tribal, and Territorial Fiscal Recovery, Infrastructure, and Disaster Relief Flexibility Act

State, Local, Tribal, and Territorial Fiscal Recovery, Infrastructure, and Disaster Relief Flexibility Act This bill allows states, tribes, territories, and localities to use certain COVID-19 relief funds for new categories of spending, including for natural disasters and infrastructure projects. It also makes changes to expenditure deadlines and other aspects of this funding. Specifically, recipients may use funds for emergency relief from natural disasters and associated negative economic impacts of natural disasters. In addition, recipients may use a portion of their COVID-19 relief funds for designated infrastructure projects, such as nationally significant freight and highway projects. Furthermore, the bill allows recipients to expend COVID-19 relief funds on these types of infrastructure projects until September 30, 2026. Under current law, recipients must expend the funds by December 31, 2024. Other changes in the bill include (1) modifying eligibility and allocation requirements for funding set aside for counties and Indian tribes that are near public lands, (2) allowing Indian tribes an additional year to expend their COVID-19 relief funds, and (3) establishing a process for government entities to decline COVID-19 relief funds and requiring any declined funds to be used to reduce the federal deficit.

In committee Oct 26, 2021 1 co-sponsor
Co-sponsor HRES 729
In committee · United States House · Co-sponsor
Expressing support for the recognition of October 2021 as "National Dyslexia Awareness Month".

This resolution supports the designation of National Dyslexia Awareness Month and calls on Congress, schools, and educational agencies to recognize that dyslexia has significant educational implications that must be addressed.

In committee Oct 20, 2021 1 co-sponsor
Co-sponsor HR 2717
In committee · United States House · Co-sponsor
Safer Schools Act of 2021

Safer Schools Act of 2021 This bill establishes a pilot program through which the Department of Justice must award grants to public elementary and secondary schools to conduct independent facility security risk assessments and make hard security improvements (e.g., video monitoring and alert notification equipment).

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 19
In committee · United States House · Co-sponsor
Lower Costs, More Cures Act of 2021

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2430
In committee · United States House · Co-sponsor
Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act

Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act This bill extends until May 6, 2022, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on May 6, 2021.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 5586
In committee · United States House · Co-sponsor
Prohibiting IRS Financial Surveillance Act

Prohibiting IRS Financial Surveillance Act This bill prohibits the Department of the Treasury from requiring a financial institution to report the transfers into and out of a financial account. This prohibition does not apply to laws or regulations in effect on October 1, 2021.

In committee Oct 15, 2021 1 co-sponsor
Primary HR 5510
In committee · United States House · Lead sponsor
Truth in Healthcare Marketing Act of 2021

Truth in Healthcare Marketing Act of 202 1 This bill prohibits as an unfair or deceptive trade practice a person from misrepresenting (1) whether the person holds a state health care license; or (2) the person's education, training, degree, license, or clinical expertise. A person's advertisement for the person's health care services must disclose the license under which the person is authorized to provide those services.

In committee Oct 11, 2021 0 co-sponsors
Primary HR 1042
In committee · United States House · Lead sponsor
Protecting Critical Infrastructure Act

Protecting Critical Infrastructure Act This bill imposes an enhanced general penalty on any person who is sentenced to imprisonment for violating certain communications laws and who willfully or maliciously destroys any communications facility during and in relation to such violation.

In committee Oct 1, 2021 0 co-sponsors
Co-sponsor HR 2748
In committee · United States House · Co-sponsor
Israel Relations Normalization Act of 2021

Israel Relations Normalization Act of 2021 This bill requires the Department of State to take certain actions promoting the normalization of relations between Israel, Arab states, and other relevant countries and regions. Specifically, the State Department must develop a strategy on expanding and strengthening the Abraham Accords (the term used to refer collectively to agreements between Israel and the United Arab Emirates and between Israel and Bahrain marking the public normalization of relations between the two Arab countries and Israel). The strategy must include a description of how the U.S. government will encourage further normalization of relations with Israel. In addition, the State Department must report on options for U.S. international efforts to promote the strengthening of ties between Israel, Arab states, and other relevant countries and regions. The State Department must also report on the status of the normalization of relations with Israel, including information on (1) laws that punish individuals for people-to-people relations with Israelis (i.e., anti-normalization laws), and (2) evidence of steps taken by Arab governments toward permitting or encouraging normalized relations between their citizens or residents and Israeli citizens.

In committee Sep 30, 2021 1 co-sponsor
Showing 421 to 430 of 556 bills
Previous 1 … 42 43 44 … 56 Next